|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q2 FY2022
As of Nov 30, 2021
|
Q4 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Investment in Hotel, net | ||||||||||||||||||||
| Investment in real estate, net | ||||||||||||||||||||
| Investment in marketable securities | ||||||||||||||||||||
| Marketable equity securities | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Due from securities broker | ||||||||||||||||||||
| Assets held for sale | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Accounts payable and other liabilities | ||||||||||||||||||||
| Accounts payable and other liabilities – Hotel | ||||||||||||||||||||
| Due to securities broker | ||||||||||||||||||||
| Obligations for securities sold | ||||||||||||||||||||
| Total related party notes payable | ||||||||||||||||||||
| Other notes payable | ||||||||||||||||||||
| Deferred tax liability | ||||||||||||||||||||
| Mortgage and mezzanine notes payable - Hotel | ||||||||||||||||||||
| Mortgage notes payable – real estate | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ deficit: | ||||||||||||||||||||
| Common stock, $.01 par value, 4,000,000 shares authorized; 3,459,888 and 3,459,888 issued; 2,148,812 and 2,154,405 outstanding as of June 30, 2026 and 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury stock, at cost, 1,311,076 and 1,305,483 shares as of June 30, 2026 and 2025, respectively | ||||||||||||||||||||
| Total InterGroup shareholders’ deficit | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total shareholders’ deficit | ||||||||||||||||||||
| Total liabilities and shareholders’ deficit | ||||||||||||||||||||
Loading...
